Janux Therapeutics Inc (JANX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $695.65M
Last updated: Nov 17, 2026 at 4:18 PM ET
Janux Therapeutics Inc (JANX) Stock Chart
Janux Therapeutics (JANX) has a latest price of $10.71 on Nov 17, 2026. Its price fell 63.4% over the past 12 months. The month-end price fell 28.3% over the 5 years through Oct 2026, a compound annual decline of 6.4%.
Price Chart
From Jun 2021 to Oct 2026, its highest month-end close was $57.00 in Apr 2024 and its lowest $6.42 in Oct 2023, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart JANX with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for JANX.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 38.9%, and over 6 months it fell 22.4%. The month-end price rose 172.1% over the 3 years through Oct 2026, a compound annual rate of 39.6%.
| Period | Change |
|---|---|
| 1 month | -36.0% |
| 3 months | -38.9% |
| 6 months | -22.4% |
| 12 months | -63.4% |
| 12 months, with dividends | -63.4% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +172.1% | +39.6% |
| 5 years | -28.3% | -6.4% |
Price by Year
Its best calendar year was 2024, when the price rose 399.0%, and its weakest was 2025, when it fell 74.2%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $17.47 | +26.6% |
| 2025 | $13.80 | -74.2% |
| 2024 | $53.54 | +399.0% |
| 2023 | $10.73 | -18.5% |
| 2022 | $13.17 | -33.2% |
Trading Range
The price is 34.8% below its 50-day average of $16.43 and 30.1% below its 200-day average of $15.33.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $10.71 | |
| 50-day average | $16.43 | -34.8% |
| 200-day average | $15.33 | -30.1% |
Price Risk
Over 3 years, its largest fall from a peak was 84.0%.
| Measure | Value |
|---|---|
| 1-year beta | 0.92 |
| Largest fall, 1 year | -69.2% |
| Largest fall, 3 years | -84.0% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About JANX
What is JANX's 1-year price change?
Janux Therapeutics's price fell 63.4% over the past 12 months. With dividends included, the 12-month total return was -63.4%.
What is JANX's 5-year price change?
Janux Therapeutics's month-end price fell 28.3% over the 5 years through Oct 2026, a compound annual decline of 6.4%. These figures leave out dividends.
What is JANX's beta?
Janux Therapeutics's 1-year beta against the S&P 500 is 0.92, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 69.2%.
Is the JANX chart free?
Yes. Advanced Charting for JANX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
JANX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors